📰 Markus Heckmann News

Markus Heckmann News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Markus Heckmann. Real-time updates on events, politics, business and more.

KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting

February 16, 2024

– Late-breaking phase 3 data for KONFIDENT trial on Sunday, February 25, 2024 – ...

United States Maeve Oconnor William Lumry Markus Heckmann Matthew Iverson Cristine Radojicic

Source: marketscreener.com

KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allerg

February 16, 2024

– Late-breaking phase 3 data for KONFIDENT trial on Sunday, February 25, 2024 –CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--$KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule pro...

United Kingdom United States Mashonaland East Paul Audhya Maeve Oconnor Neil Malloy

Source: pharmiweb.com

KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 US HAEA National Summit

July 14, 2023

KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the...

United States Sherry Danese Russella Settipane Kelley Myers Paulaj Busse Shawn Czado

Source: marketscreener.com

NEW NOW Festival for Digital Arts - e-flux Agenda

May 25, 2023

NEW NOW Festival for Digital Arts 2023 opens in Essen, Germany.

Nordrhein Westfalen Kathrin Yacavone Jana Kerima Stolzer Felix Maschewski Neue Ku Sam Balfus

Source: e-flux.com

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop

April 27, 2023

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today

Erik Hansen Matthew Iverson Sally Van Kooten Studyvibha Desai Sallyl Hampton Michaeld Smith

Source: finanznachrichten.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Rick Silva shares his top ten - Artforum International

April 1, 2023

Rick Silva is an artist and professor who was born in Brazil and is currently based in Eugene, Oregon. His videos, websites, and installations explore virtuality, futurology, and speculative ecologies. A selection of Silva’s work is currently being featured in “I’ll Be Your Mirror: Art and the Digital Screen” at the Modern in Fort Worth, where it is up through the end of this month. His newest piece, LIQUID CRYSTAL, 2023, commissioned by the Whitney Museum of American Art in New York, wi...

New York United States Whitney Museum Of American Art Three Sisters Wilderness Four Tet Erick Silva

Source: artforum.com

KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology

February 16, 2023